(VAP-1,67.82682865573561)
(ST-2,67.82682865573561)
(DSCAM-AS1,58.78325150163752)
(Nek6,49.73967434753945)
(microRNA-22,45.217885770490405)
(miR-511,40.69609719344136)
(variants,38.286413964890954)
(subsequent,37.046911220467884)
(signatures,37.046911220467884)
(radiomics,36.174308616392324)
(ERalpha,36.174308616392324)
(FXYD3,36.174308616392324)
(Zt/g4-MMAE,36.174308616392324)
(AD,36.174308616392324)
(rs5743810,36.174308616392324)
(users,32.93058775152701)
(mutations,32.690256085536724)
(BPE,31.652520039343283)
(miR-204-5p,31.652520039343283)
(AION,31.652520039343283)
(STAT1,31.652520039343283)
(hypomethylation,31.652520039343283)
(nipple,31.652520039343283)
(neoadjuvant,28.81426428258613)
(factors,27.159400622454896)
(lung/bronchus,27.130731462294243)
(cTn,27.130731462294243)
(AMD3100,27.130731462294243)
(nondestructive,27.130731462294243)
(NSAID,27.130731462294243)
(TAMs,27.130731462294243)
(cutoff,27.130731462294243)
(membrane,27.130731462294243)
(RON,27.130731462294243)
(TAM,27.130731462294243)
(DDT,24.697940813645253)
(LVEF,24.697940813645253)
(cytology,24.697940813645253)
(trastuzumab,24.697940813645253)
(CTC,24.697940813645253)
(genes,23.962234018666514)
(M,22.97184837893457)
(hypomethylated,22.608942885245202)
(nanoplatform,22.608942885245202)
(PCOS,22.608942885245202)
(capecitabine,22.608942885245202)
(presentations,22.608942885245202)
(neuromas,22.608942885245202)
(PCDH10,22.608942885245202)
(chorea,22.608942885245202)
(NSAIDs,22.608942885245202)
(accumulation,22.608942885245202)
(stigmatization,22.608942885245202)
(mastectomies,22.608942885245202)
(subtype,21.632987071049314)
(radiotherapy,20.58161734470438)
(miRNAs,19.143206982445477)
(treatments,19.143206982445477)
(MORC4,18.087154308196162)
(FOXC1,18.087154308196162)
(MSOT,18.087154308196162)
(miR-34s,18.087154308196162)
(MF3,18.087154308196162)
(SE,18.087154308196162)
(US,18.087154308196162)
(AYAs,18.087154308196162)
(matrices,18.087154308196162)
(FFDM,18.087154308196162)
(miR-193b-3p,18.087154308196162)
(G,18.087154308196162)
(MABA,18.087154308196162)
(sleep,18.087154308196162)
(CA,18.087154308196162)
(behaviours,18.087154308196162)
(DNA,18.087154308196162)
(sprays,18.087154308196162)
(personal,18.087154308196162)
(Kenya,18.087154308196162)
(isolation,18.087154308196162)
(replaced,18.087154308196162)
(Saudi,18.087154308196162)
(areola,18.087154308196162)
(PM,18.087154308196162)
(fibroblasts,18.087154308196162)
(third-line,18.087154308196162)
(autoantibodies,18.087154308196162)
(Baicalin,18.087154308196162)
(SLN,18.087154308196162)
(baicalin,18.087154308196162)
(Arabian,18.087154308196162)
(RRM2,18.087154308196162)
(Japanese,18.087154308196162)
(interval,18.087154308196162)
(ClearCell,18.087154308196162)
(CLB-Pt-CLB,18.087154308196162)
(aspirin,18.087154308196162)
(CNVs,18.087154308196162)
(aptamer,18.087154308196162)
(parameters,18.027489225874426)
(resistance,17.11588144190465)
(risk,16.635532333438686)
(mechanism,16.465293875763503)
(male,16.465293875763503)
(baseline,16.465293875763503)
(lymphedema,16.465293875763503)
(survival,15.455270567962362)
(will,15.31456558595638)
(values,15.31456558595638)
(learning,15.31456558595638)
(exposure,15.31456558595638)
(long-term,15.31456558595638)
(issues,15.31456558595638)
(participants,15.31456558595638)
(PFS,15.31456558595638)
(biopsy,15.088555901363831)
(result,14.421991380699541)
(proportion,13.692705153523722)
(young,13.692705153523722)
(sentinel,13.692705153523722)
(cohort,13.692705153523722)
(forefront,13.565365731147121)
(Computer,13.565365731147121)
(Carbon,13.565365731147121)
(chlorambucil,13.565365731147121)
(160,13.565365731147121)
(toxicity,13.565365731147121)
(vitro,13.565365731147121)
(carrier,13.565365731147121)
(axis,13.565365731147121)
(post-diagnosis,13.565365731147121)
(aspiration,13.565365731147121)
(addressed,13.565365731147121)
(STs,13.565365731147121)
(mTOR,13.565365731147121)
(inverse,13.565365731147121)
(greaterThanOrEqualTo,13.565365731147121)
(GLUT1,13.565365731147121)
(Cholecystectomy,13.565365731147121)
(TAAs,13.565365731147121)
(Oestrogen,13.565365731147121)
(post-NAC,13.565365731147121)
(hyperglycemia,13.565365731147121)
(DESI-MSI,13.565365731147121)
(susceptibility,13.565365731147121)
(periods,13.565365731147121)
(yoga,13.565365731147121)
(analytics,13.565365731147121)
(DOX,13.565365731147121)
(macrophages,13.565365731147121)
(Individuals,13.565365731147121)
(City,13.565365731147121)
(heterogeneity,13.565365731147121)
(SNVs,13.565365731147121)
(inhibitor,13.565365731147121)
(mother,13.565365731147121)
(15-3,13.565365731147121)
(vivo,13.565365731147121)
(late-stage,13.565365731147121)
(subgroup,13.565365731147121)
(regulatory,13.565365731147121)
(Researchers,13.565365731147121)
(PR,13.565365731147121)
(pleurodesis,13.565365731147121)
(CEDM,13.565365731147121)
(Axillary,13.565365731147121)
(subtype-specific,13.565365731147121)
(Mutations,13.565365731147121)
(Associations,13.565365731147121)
(adverse,13.565365731147121)
(Tumor,13.565365731147121)
(WHI,13.565365731147121)
(consensus,13.565365731147121)
(towavelet,13.565365731147121)
(apatinib,13.565365731147121)
(collision,13.565365731147121)
(Osteopontin-750,13.565365731147121)
(Almaty,13.565365731147121)
(quantification,13.565365731147121)
(goal-setting,13.565365731147121)
(Access,13.565365731147121)
(protein-1,13.565365731147121)
(output,13.565365731147121)
(Herceptin,13.565365731147121)
(utilized,13.565365731147121)
(guidelines,13.565365731147121)
(expert,13.565365731147121)
(dioxide,13.565365731147121)
(disturbances,13.565365731147121)
(authors,13.565365731147121)
(capillaries,13.565365731147121)
(everolimus,13.565365731147121)
(food,13.565365731147121)
(anastrozole,13.565365731147121)
(ecchymosis,13.565365731147121)
(decrease,13.565365731147121)
(mannose,13.565365731147121)
(Treatment,13.565365731147121)
(craniotomy,13.565365731147121)
(short-term,13.565365731147121)
(surgeries,13.565365731147121)
(Baseline,13.565365731147121)
(pure,13.565365731147121)
(RNAs,13.565365731147121)
(comorbidities,13.565365731147121)
(depletion,13.565365731147121)
(contraception,13.565365731147121)
(assays,13.565365731147121)
(Obesity,13.565365731147121)
(Investigation,13.565365731147121)
(syndrome,13.565365731147121)
(Pathogenic,13.565365731147121)
(glycosylation,13.565365731147121)
(GTPase,13.565365731147121)
(186,13.565365731147121)
(Mammographic,13.565365731147121)
(odds,13.565365731147121)
(signalling,13.565365731147121)
(relative,13.565365731147121)
(infrared,13.565365731147121)
(focused,13.565365731147121)
(244,13.565365731147121)
(irregular,13.565365731147121)
(Kazakhstan,13.565365731147121)
(Spouses,13.565365731147121)
(limitations,13.565365731147121)
(10-year,13.565365731147121)
(filter,13.565365731147121)
(troponins,13.565365731147121)
(subset,13.565365731147121)
(laser,13.565365731147121)
(basis,13.565365731147121)
(93,13.565365731147121)
(MR,13.565365731147121)
(components,13.565365731147121)
(paraneoplastic,13.565365731147121)
(distance,13.565365731147121)
(weight,13.565365731147121)
(germline,13.565365731147121)
(positivity,13.565365731147121)
(SNPs,13.565365731147121)
(nano-genosensor,13.565365731147121)
(costs,13.565365731147121)
(77,13.565365731147121)
(CA15-3,13.565365731147121)
(atypia,13.565365731147121)
(base,13.565365731147121)
(random-sampling,13.565365731147121)
(nanocarrier,13.565365731147121)
(sizeThe,13.565365731147121)
(SPD,13.565365731147121)
(Conclusions,13.565365731147121)
(platinum,13.565365731147121)
(alterations,13.565365731147121)
(Mortality,13.565365731147121)
(hyperintense,13.565365731147121)
(percent,13.565365731147121)
(of121,13.565365731147121)
(low-dose,13.565365731147121)
(neuroma,13.565365731147121)
(Traumatic,13.565365731147121)
(hazard,13.07610243421469)
(correlation,13.07610243421469)
(locoregional,12.348970406822627)
(circulating,12.348970406822627)
(center,12.348970406822627)
(finding,12.348970406822627)
(amplification,12.348970406822627)
(apoptosis,12.348970406822627)
(description,12.348970406822627)
(immunohistochemistry,12.348970406822627)
(protocols,12.348970406822627)
(syndromes,12.348970406822627)
(Estrogen,12.348970406822627)
(European,12.348970406822627)
(sensitive,12.348970406822627)
(cardiac,12.348970406822627)
(reduced,12.348970406822627)
(CNN,12.348970406822627)
(cross-validation,12.348970406822627)
(predictors,12.348970406822627)
(HER2-positive,12.348970406822627)
(advantage,12.348970406822627)
(Chinese,12.348970406822627)
(signature,12.348970406822627)
(SOX9,12.348970406822627)
(alpha,12.348970406822627)
(estrogens,12.348970406822627)
(techniques,12.348970406822627)
(symptom,12.348970406822627)
(elusive,12.348970406822627)
(design,12.348970406822627)
(reporter,12.348970406822627)
(complex,12.070844721091065)
(She,11.485924189467285)
(platform,11.485924189467285)
(prevention,11.485924189467285)
(regimens,11.485924189467285)
(coefficient,11.485924189467285)
(hereditary,11.485924189467285)
(survivors,11.485924189467285)
(antibody,11.485924189467285)
(purpose,11.485924189467285)
(testing,11.485924189467285)
(prior,10.816493535524657)
(binding,10.816493535524657)
(targeted,10.816493535524657)
(Cox,10.816493535524657)
(sites,10.816493535524657)
(postmenopausal,10.816493535524657)
(enhancer,10.816493535524657)
(technique,10.269528865142792)
(proliferation,10.269528865142792)
(network,10.269528865142792)
(required,10.269528865142792)
(image,10.269528865142792)
(OS,10.269528865142792)
(care,10.027542226027103)
(cell,10.027542226027103)
(subtypes,9.807076825661017)
(HER2,9.807076825661017)
(levels,9.807076825661017)
(strategy,9.807076825661017)
(number,9.807076825661017)
(Women,9.406482647787449)
(type,9.0531335408183)
(Patients,9.0531335408183)
(adult,9.043577154098081)
(aberrances,9.043577154098081)
(adulthood,9.043577154098081)
(caregiver,9.043577154098081)
(Demographics,9.043577154098081)
(provider,9.043577154098081)
(MiRNA,9.043577154098081)
(activities,9.043577154098081)
(Pearson,9.043577154098081)
(intrapulmonary,9.043577154098081)
(TBR,9.043577154098081)
(Propensity,9.043577154098081)
(parietal,9.043577154098081)
(monomethyl,9.043577154098081)
(Bayes,9.043577154098081)
(Carlo,9.043577154098081)
(post,9.043577154098081)
(Overexpression,9.043577154098081)
(phosphorylation,9.043577154098081)
(nonparticipation,9.043577154098081)
(spouse,9.043577154098081)
(preterm,9.043577154098081)
(Cell,9.043577154098081)
(Omega,9.043577154098081)
(debated,9.043577154098081)
(Annexin,9.043577154098081)
(differentials,9.043577154098081)
(specimen,9.043577154098081)
(discovery,9.043577154098081)
(Co-existence,9.043577154098081)
(acids,9.043577154098081)
(oxidation,9.043577154098081)
(box,9.043577154098081)
(Matthews,9.043577154098081)
(Zt/g4-drug,9.043577154098081)
(clinical-pathological,9.043577154098081)
(subtyped,9.043577154098081)
(CMIA,9.043577154098081)
(switched,9.043577154098081)
(township,9.043577154098081)
(Urgent,9.043577154098081)
(Acupuncture,9.043577154098081)
(rural-based,9.043577154098081)
(Various,9.043577154098081)
(originally,9.043577154098081)
(BRCA1,9.043577154098081)
(canines,9.043577154098081)
(autoimmune,9.043577154098081)
(formed,9.043577154098081)
(simulated,9.043577154098081)
(ER-positive/human,9.043577154098081)
(age-matched,9.043577154098081)
(noncoding,9.043577154098081)
(black,9.043577154098081)
(capabilities,9.043577154098081)
(Summaries,9.043577154098081)
(entry,9.043577154098081)
(individualized,9.043577154098081)
(Ovarian,9.043577154098081)
(necessity,9.043577154098081)
(consensus-based,9.043577154098081)
(Circulating,9.043577154098081)
(pathologically,9.043577154098081)
(personalized,9.043577154098081)
(predominant,9.043577154098081)
(greater,9.043577154098081)
(nucleus,9.043577154098081)
(tolerabilityThe,9.043577154098081)
(Relapse,9.043577154098081)
(oligonucleotides,9.043577154098081)
(selection-based,9.043577154098081)
(estimates,9.043577154098081)
(Immunohistochemical,9.043577154098081)
(16,9.043577154098081)
(Gene,9.043577154098081)
(spouses,9.043577154098081)
(cell-killing,9.043577154098081)
(biocharacter,9.043577154098081)
(vulnerability,9.043577154098081)
(estrogen-alone,9.043577154098081)
(mimics,9.043577154098081)
(RL,9.043577154098081)
(therapy-related,9.043577154098081)
(Polycystic,9.043577154098081)
(Texture,9.043577154098081)
(spread,9.043577154098081)
(danger,9.043577154098081)
(robust,9.043577154098081)
(Comparisons,9.043577154098081)
(Reverse,9.043577154098081)
(manufactured,9.043577154098081)
(643,9.043577154098081)
(systematic,9.043577154098081)
(BRCA1/2,9.043577154098081)
(numerous,9.043577154098081)
(comparisons,9.043577154098081)
(MAb,9.043577154098081)
(miRNA-21,9.043577154098081)
(endocrine-resistant,9.043577154098081)
(interference,9.043577154098081)
(Asymptomatic,9.043577154098081)
(solicitations,9.043577154098081)
(CS/Bio-MOF,9.043577154098081)
(Seven,9.043577154098081)
(Its,9.043577154098081)
(Validation,9.043577154098081)
(Factor,9.043577154098081)
(osteopontin,9.043577154098081)
(desirable,9.043577154098081)
(fertility,9.043577154098081)
(505,9.043577154098081)
(scientific,9.043577154098081)
(water,9.043577154098081)
(conjugates,9.043577154098081)
(linear,9.043577154098081)
(obstetricians,9.043577154098081)
(pathologic,9.043577154098081)
(scalable,9.043577154098081)
(Detection,9.043577154098081)
(greaterfor,9.043577154098081)
(race/color,9.043577154098081)
(hybrid,9.043577154098081)
(delays,9.043577154098081)
(multiplex,9.043577154098081)
(obstetrician,9.043577154098081)
(understudied,9.043577154098081)
(9398,9.043577154098081)
(Monte,9.043577154098081)
(evolve,9.043577154098081)
(considerable,9.043577154098081)
(situations,9.043577154098081)
(allele,9.043577154098081)
(Multi-stimuli-responsive,9.043577154098081)
(Transcripts,9.043577154098081)
(global,9.043577154098081)
(10-fold,9.043577154098081)
(1-2,9.043577154098081)
(propagation-based,9.043577154098081)
(revealed,9.043577154098081)
(targets,9.043577154098081)
(phenotype,9.043577154098081)
(V-G,9.043577154098081)
(scans,9.043577154098081)
(auristatin,9.043577154098081)
(intensity,9.043577154098081)
(supplements,9.043577154098081)
(conjugate,9.043577154098081)
(PA,9.043577154098081)
(contribution,9.043577154098081)
(focus,9.043577154098081)
(Anemia,9.043577154098081)
(JAK-STAT,9.043577154098081)
(somatic,9.043577154098081)
(satisfied,9.043577154098081)
(chosen,9.043577154098081)
(conflict,9.043577154098081)
(overexpressing,9.043577154098081)
(T2,9.043577154098081)
(DDTs,9.043577154098081)
(actual,9.043577154098081)
(distinct,9.043577154098081)
(circRNAs,9.043577154098081)
(benchmark,9.043577154098081)
(subjective,9.043577154098081)
(mood,9.043577154098081)
(Brain,9.043577154098081)
(Poisson,9.043577154098081)
(Microfluidic,9.043577154098081)
(bromide,9.043577154098081)
(Steps,9.043577154098081)
(decision-making,9.043577154098081)
(restoration,9.043577154098081)
(KDM4B,9.043577154098081)
(Cardiac,9.043577154098081)
